Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus.[2] Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida.[3][4][5] In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.[6][7]
Funding for construction of the initial $70 million facility came primarily from the state of Florida's cigarette tax, while the momentum to create the center came from a cadre of legislators, physicians, educators, and business leaders who envisioned a new dimension of cancer care and research in Florida.
In late 1978, H. Lee Moffitt, a Florida state representative, recognized the need for a comprehensive cancer center within the state after several friends died from cancer. An excellent negotiator, Moffitt put his plan into motion by first proposing the idea to Hollis Boren, then dean of the University of South Florida College of Medicine. Over lunch at the Tampa Club, Moffitt proposed his idea. By dessert, Boren has signed on. "Out of that discussion came plans for a plug-shaped, multilevel cancer research teaching hospital to be built a short walk away from the USF clinics," The Tampa Times reported on February 5, 1979. Moffitt and Boren had gathered information about the need for a comprehensive cancer center, the article said, and the need was great.[8][9]
Moffitt sought community support and convinced the State Legislature to fund the facility. During the center's planning phase, consultants associated with NCI-designated Cancer Centers were retained to ensure that the finished facility would be as technologically advanced and as efficiently designed as possible.
Groundbreaking ceremonies took place in January 1983. The center was incorporated in the spring of 1984 and was named for Houston Lee Moffitt, then Speaker of the State House of Representatives. The building was dedicated in October 1986 and admitted its first patients that same month.
In 1990, the acquisition of the Research Center building across from the Cancer Center enhanced the recruitment of scientists, clinicians, and support staff, and expanded Moffitt's vision beyond the original structure. The Moffitt Research Center became the focal point for basic and translational cancer research, with the overriding goal to produce discoveries that could be translated quickly from the bench to the patient's bedside. The Florida Legislature allocated $12 million for renovation and equipment for this 100,000-square-foot (9,300m2) structure, and the Moffitt Research Center became fully operational in 1995. In 1999, 48,000 square feet (4,500m2) of basic research lab space was added to the Moffitt Research Center at a cost of $11 million to house the growing need for additional scientists.
In 2022 the Florida Legislature approved more than $706 million for a new H. Lee Moffitt Cancer Center and Research Institute campus in Pasco County. $600 million in state funding will be distributed in yearly in $20 million yearly increments for each of the next 30 years.[10]
Organization
On June 10, 1998, in a ceremonial signing at Moffitt, Florida governorLawton Chiles approved a legislative initiative to fund construction of the Moffitt Tower Project, which opened in April 2003, adding more than 350,000 square feet (33,000m2) of new space. This expansion includes the Vincent A. Stabile Research Building, eponymously named in recognition of the largest private donation ever made to the Cancer Center. The new construction also includes an expansion of the Moffitt Clinic. In addition to new research laboratories, which nearly double the cancer center's research capabilities, the new facilities include a digital imaging center, and a new infusion center.
In 1991, John Ruckdeschel, assumed the position of center director, president and CEO. Under Ruckdeschel's leadership, Moffitt became a National Cancer Institute (NCI) Comprehensive Cancer Center. In 2017,[11] the NCI renewed Moffitt's Cancer Center Support Grant for another five years. Currently, Moffitt receives more than $50 million annually in peer-reviewed grant monies.
In 2002, Ruckdeschel stepped down, and William Dalton, became Moffitt's third president, CEO and center director.
On June 24, 2011, Moffitt Cancer Center opened the first blood and marrow transplant (BMT) clinic in Puerto Rico.[19]
On July 1, 2011, Moffitt Cancer Center opened a new 50,000-square-foot satellite facility at International Plaza. The building replaced Moffitt's former outpatient center at Tampa General Hospital.[20][21]
In July 2012, William Dalton, became the CEO of M2Gen and Moffitt's new Personalized Medicine Institute. Alan List, who previously served as Moffitt's executive vice president/physician-in-chief and president of the Moffitt Medical Group, succeeded Dalton as CEO and president. Thomas Sellers assumed the role of center director.[22]
In February 2013, Moffitt began construction of a $74.2 million outpatient facility on the cancer center's 30-acre property on N McKinley Drive, about a mile from Moffitt's main campus.[23]
In November 2015, Moffitt opens the McKinley Outpatient Center. The six-story, 207,000-square-foot facility at 10920 N McKinley Drive is located about a mile from the main campus. Services on the site include the skin and breast cancer clinics, four operating rooms, an imaging suite, research labs, space for blood draws and a Publix pharmacy.[24]
In July 2017, Moffitt and Memorial Healthcare announce a partnership to establish a comprehensive blood and marrow transplant cellular therapy program for South Florida residents. The alliance brings the renowned cancer center's access to research, clinical trials, and comprehensive treatment to leukemia, lymphoma and multiple myeloma patients.[25]
In August 2020, Moffitt named Patrick Hwu, a tumor immunologist with 33 years of oncology experience, its new president and CEO.[26]
Research and Treatment
Through clinical trials, Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt, and researchers at Moffitt Cancer Center discovered two monotherapy drugs – Mekinist (trametinib) and Tafinlar (dabrafenib) – can be safely combined to overcome or delay treatment resistance for a large percentage of melanoma patients with a specific gene mutation. Approved by the FDA in January 2014, Mekinist in combination with Tafinlar is one of the biggest advancements in melanoma treatment in the past 30 years.[27]
In August 2011, the U.S. Food and Drug Administration (FDA) approved the drug vemurafenib (Zelboraf) for metastatic melanoma patients who test positive for a specific gene mutation. Moffitt Cancer Center conducted a registration trial using the drug manufactured by Genentech, a member of the Roche Group.[28]
Anna Giuliano, director of Moffitt's Center for Infection Research in Cancer, led two studies on human papillomavirus (HPV) infection in men. Her work strengthened the Food & Drug Administration (FDA) recommendation for boys and men to receive HPV vaccinations and provided useful data for the development of realistic cost-effectiveness models for male HPV vaccination internationally.[29]
In September 2014, a new cancer immunotherapy for melanoma patients called Keytruda became the first anti-PD-1 (programmed death receptor-1) therapy approved in the United States. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence at Moffitt, was one of the lead investigators of the clinical trial which led to the drug receiving breakthrough status from the FDA.[30]
In January 2016, researchers at Moffitt teamed up with the state of Florida in a study to see if making fruits and vegetables available to children who otherwise may not have them readily available can decrease their risk of cancer.[31]
In October 2017, the Food and Drug Administration announced the approval of Yescarta™, a revolutionary new immunotherapy for adult patients with diffuse large B cell lymphoma, a form of non-Hodgkin's lymphoma. Yescarta is a Chimeric Antigen Receptor (CAR) T cell therapy, also known as CAR-T. Moffitt Cancer Center's Frederick Locke, is the co-lead investigator of the pivotal ZUMA-1 clinical trial that tested the new therapy, which is manufactured by Kite, a Gilead company.[32]
In February 2024, the U.S. Food and Drug Administration approved a first-of-its-kind immunotherapy pioneered at Moffitt for patients with advanced melanoma.[33] Moffitt was a driving force in getting lifileucel (Amtagvi) FDA-approved for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.[34]
Moffit Cancer Center is located on the campus of the University of South Florida in north Tampa. The center includes the hospital, Muriel Rothman Building (clinic), Vincent A. Stabile Research Building and the Moffitt Research Center.[38]
Moffitt at International Plaza is a 50,000-square-foot full service outpatient facility near Tampa International Airport. The facility includes physician office visits, infusion services, radiation and radiology.[39]
McKinley Outpatient Center
Moffitt Cancer Center Prevention Research, Fowler Campus, located in north Tampa, is a facility that practices research for prevention and early detection of cancer.[40]
The Richard M. Schulze Family Foundation Outpatient Center at McKinley Campus,[41] 10920 N. McKinley Drive, includes the breast and skin cancer clinics, infusion center, research labs and four surgery suites.[42]
Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, 801 N. Flamingo Road, Pembroke Pines, FL, provides a comprehensive Blood and Marrow Transplant Cellular Therapy Program for South Florida residents.[43]
Moffitt Cancer Center at Wesley Chapel, 2590 Healing Way, Wesley Chapel, FL, is a 28,000-square-foot outpatient facility bringing access to Moffitt expertise and nationally-ranked cancer care to Pasco County.[44]
Moffitt McKinley Hospital, 10901 N. McKinley Drive, Tampa, FL, is an inpatient surgical hospital located on Moffitt's McKinley Campus. The 10-story, 500,000-square-foot facility provides patients with the latest innovations in surgical techniques and inpatient care.[45]
Moffitt Cancer Center at Port Tampa Bay, 651 Channelside Drive, Tampa, FL, is a community outreach and education center near downtown Tampa.[46]
Recognition
From 1999 to 2019, Moffitt has been ranked one of "America's Best Hospitals" for cancer by U.S. News & World Report.[47]
In 2014, Becker's Hospital Review includes Moffitt in the 100 Accountable Care Organizations to Know.[48]
In 2015, Moffitt earned a Magnet designation for nursing excellence, granted by the American Nurses Credentialing Center (ANCC), the credentialing body of the American Nurses Association.[49][verification needed]
In 2015, Becker's Hospital Review recognizes Moffitt's president and CEO Dr. Alan List in its "100 Physician Leaders of Hospitals and Health Systems."[50]
Moffitt Cancer Center was named 2017 Nonprofit of the Year by the Tampa Bay Business Journal. Moffitt was also recognized as the category winner in the Health & Human Services category.[51]
In 2018, Moffitt was named LGBTQ Healthcare Equality Leader by the Human Rights Campaign Foundation.[52] The cancer center was also named one of Working Mother Magazine's 100 Best Companies for 10th time.[53]
In 2023, Moffitt was ranked No. 10 in the nation and the top-ranked cancer hospital in Florida and the Southeast in Newsweek’s 2023 list of “America’s Best Cancer Hospitals.”[54]
Mayo Clinic is a nonprofit American academic medical center focused on integrated health care, education, and research. It employs over 7,300 physicians and scientists, along with another 66,000 administrative and allied health staff, across three major campuses: Rochester, Minnesota; Jacksonville, Florida; and Phoenix/Scottsdale, Arizona. The practice specializes in treating difficult cases through tertiary care and destination medicine. It is home to the top-15 ranked Mayo Clinic Alix School of Medicine in addition to many of the highest regarded residency education programs in the United States. It spends over $660 million a year on research and has more than 3,000 full-time research personnel.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. It had already been renamed and relocated, to its present site, when the Sloan-Kettering Institute for Cancer Research was founded in 1945, and built adjacent to the hospital. The two medical entities formally coordinated their operations in 1960, and formally merged as a single entity in 1980. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.
Shriners Children's is a network of non-profit medical facilities across North America. Children with orthopaedic conditions, burns, spinal cord injuries, and cleft lip and palate are eligible for care and receive all services in a family-centered environment, regardless of the patients' ability to pay. Care for children is usually provided until age 18, although in some cases, it may be extended to age 21.
UC San Diego Health is the academic health system of the University of California, San Diego in San Diego, California. It is the only academic health system serving San Diego and has one of three adult Level I trauma centers in the region. In operation since 1966, it comprises three major hospitals: UC San Diego Medical Center in Hillcrest, Jacobs Medical Center in La Jolla, and UC San Diego Health East Campus Medical Center in East County. The La Jolla campus also includes the Moores Cancer Center, Shiley Eye Institute, Sulpizio Cardiovascular Center, and Koman Family Outpatient Pavilion, and the health system also includes several outpatient sites located throughout San Diego County. UC San Diego Health works closely with the university's School of Medicine and Skaggs School of Pharmacy to provide training to medical and pharmacy students and advanced clinical care to patients.
The University of Vermont Medical Center (UVMMC) is a five-campus academic medical facility under the corporate umbrella of the University of Vermont Health Network that is anchored by a 562-bed hospital in Burlington, Vermont. UVMMC is based in Burlington and serves as both a regional referral center and a community hospital. The hospital was formerly known as the Medical Center Hospital of Vermont and later as Fletcher Allen Health Care until getting its current name. It is affiliated with the University of Vermont's Robert Larner College of Medicine and its College of Nursing and Health Sciences.
Johns Hopkins All Children's Hospital, formerly All Children's Hospital, is a pediatric acute care children's hospital located in St. Petersburg, Florida. The hospital has 259 beds and is affiliated with the USF Morsani College of Medicine and Johns Hopkins University School of Medicine. The hospital provides comprehensive pediatric specialties and subspecialties to pediatric patients aged 0–21 throughout western Florida. Johns Hopkins All Children's Hospital also features a Level 2 Pediatric Trauma Center.
Spartanburg Regional Healthcare System(SRHS) is one of South Carolina's largest healthcare systems. SRHS draws patients primarily from the areas of Spartanburg, Cherokee, Union, and Greenville counties (all located in the Piedmont region of South Carolina), as well as Rutherford and Polk counties (located in western North Carolina). Spartanburg General Hospital was organized under the authority of the South Carolina General Assembly in 1917. It officially became the Spartanburg Regional Health Services District, Inc., a political subdivision of the State of South Carolina, by the charter granted by the Secretary of State of South Carolina on May 1, 1995.
UF Health Jacksonville is a teaching hospital and medical system of the University of Florida in Jacksonville, Florida, United States. Part of the larger University of Florida Health system, it includes the 603-bed UF Health Jacksonville hospital, the 92-bed UF Health North hospital, associated clinics, and is the Jacksonville campus of UF's Health Science Center. Together with UF Health Shands Hospital in Gainesville, UF Health Jacksonville is one of two academic hospitals in the UF Health system, and serves 19 counties in Florida and several in Georgia.
UF Health Shands Hospital is a teaching hospital of the University of Florida in Gainesville, Florida. It is one of seven hospitals in the University of Florida Health system, and one of two campuses for UF's Health Science Center, the other being UF Health Jacksonville.
University of South Florida Morsani College of Medicine is one of the graduate schools of the University of South Florida.
The University of South Florida College of Nursing is one of 14 colleges at the University of South Florida. The college has three campuses: Tampa, St. Petersburg, and Sarasota-Manatee.
Baptist Health (Jacksonville) is a faith-based, non-profit health system comprising 7 hospitals with 1,168 beds, a cancer center, four satellite emergency departments and more than 200 patient access points of care, including 50 primary care offices located throughout northeast Florida and southeast Georgia. The headquarter is in Jacksonville, Florida.
Scripps Health is a nonprofit health care system based in San Diego, California. The system includes five hospitals and 19 outpatient facilities, and treats a half-million patients annually through 2,600 affiliated physicians.
Mayo Clinic Florida is a comprehensive medical center belonging to the Mayo Clinic in Jacksonville, Florida. It is one of three Mayo campuses along with Phoenix/Scottsdale, Arizona and Rochester, Minnesota.
Nebraska Medicine, is a private not-for-profit American healthcare company based in Omaha, Nebraska. The company was created as Nebraska Health System (NHS) in 1997, when Bishop Clarkson Hospital merged with the adjacent University Hospital in midtown Omaha. Renamed The Nebraska Medical Center in 2003, in 2014 the company merged with UNMC Physicians and Bellevue Medical Center to become Nebraska Medicine. The company has full ownership of two hospitals and 39 specialty and primary care clinics in and around Omaha, with partial ownership in two rural hospitals and a specialty hospital. Nebraska Medicine's main campus, Nebraska Medicine – Nebraska Medical Center, has 718 beds, while its Bellevue Medical Center campus has 91 beds.
The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 440 faculty members and 380 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs.
The ÇOMÜ Hospital is the biggest research and teaching hospital in the Western Marmara region of Turkey which serves the area of north Aegean and South-West Marmara regions. The current president and chief executive officer is Dr. Murat Coşar. The hospital is a 160-bed facility that provides patients with a complete range of primary and specialty care services.
Gibbs Cancer Center & Research Institute is a cancer treatment and research facility in Upstate South Carolina. Gibbs Cancer Center is associated with the NCI Community Cancer Centers Program and the Medical University of South Carolina. Gibbs has several locations across the upstate of South Carolina, including Comprehensive Cancer Centers at both Spartanburg Medical Center and Pelham Medical Center. Additional infusion facilities are located in Gaffney, Union, Mary Black and North Grove.
Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington. Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. Together, these four institutions form the Fred Hutch/University of Washington Cancer Consortium.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
